Cargando…
Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology
Waldenstrom's Macroglobulinemia is a low-grade B-cell lymphoma characterized by the presence of lymphoplasmacytic cells in the bone marrow and a monoclonal immunoglobulin M in the circulation. Recent evidences support the hypothesis that epigenetic modifications lead to Waldesntrom cell prolife...
Autores principales: | Sacco, Antonio, Issa, Ghayas C, Zhang, Yong, Liu, Yang, Maiso, Patricia, Ghobrial, Irene M, Roccaro, Aldo M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964547/ https://www.ncbi.nlm.nih.gov/pubmed/20929526 http://dx.doi.org/10.1186/1756-8722-3-38 |
Ejemplares similares
-
Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
por: Sacco, Antonio, et al.
Publicado: (2010) -
Candidate genes of Waldenström’s macroglobulinemia: current evidence and research
por: Bianchi, Giada, et al.
Publicado: (2013) -
The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions
por: Sacco, Antonio, et al.
Publicado: (2017) -
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia
por: Bouyssou, Juliette M., et al.
Publicado: (2018) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022)